http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101884467-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bc2ee6c9d0e012cab7114a95a3da543 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-145 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 |
| filingDate | 2017-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc9dc470870e0e906ebf974ecb624007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cfe6d99d84b0d3db475dc12e4b7d8be |
| publicationDate | 2018-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101884467-B1 |
| titleOfInvention | Liquid composition comprising alginate or a pharmaceutically acceptable salt thereof, and polysaccharide colloids |
| abstract | The present invention relates to a liquid phase containing a solution of alginic acid or a pharmaceutically acceptable salt thereof and a colloidal polysaccharide suitable as a biomaterial for medical tissue recovery used for raising the mucosal tissues when excising mucosal tissues such as stomach or intestines with an endoscope, More particularly, the present invention relates to a pharmaceutical composition for medical use for injecting into a submucosal layer in endoscopic mucosal resection (EMR) or endoscopic submucosal dissolution (ESD), comprising an alginic acid having a weight average molecular weight of 100,000 or more and less than 200,000 or A pharmaceutically acceptable salt thereof, and a liquid composition containing a colloidal polysaccharide. According to the present invention, endoscopic mucosal resection or endoscopic submucosal dissolution can be effectively used as a submucosal local injection agent having an excellent duration of mucosal uplift by injection. |
| priorityDate | 2017-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.